Expert Consensus on the use of autologous platelet-rich plasma in the context of regenerative medicine: moving forward to good clinical practice. | Synapse
March 25, 2026
Expert Consensus on the use of autologous platelet-rich plasma in the context of regenerative medicine: moving forward to good clinical practice.
Key Points
The aim is to clarify the use of autologous platelet-rich plasma (PRP) in regenerative medicine and establish good clinical practices.
Encouragement of multicentre research initiatives
Recommendations for strict publication standards
Promotion of international collaboration
Strengthened scientific foundations for the application of PRP
Guidelines for effective clinical practices in regenerative medicine
Abstract
The EC encourages multicentre research, strict publication standards, and international collaboration to strengthen scientific foundations for PRP use in regenerative medicine.